Anabolic steroids causing growth of benign tumors: Androgen receptor in angiolipomas - 19/08/11
Doi : 10.1016/j.jaad.2007.06.012
Sajjad P. Syed, MD a, ⁎ 
, David G. Brooks, MD b, Helen M. Haupt, MD c, Kirsten Bellucci, MD d, Anne-Marie Martin, PhD e, Victoria Podolski, MT (ASCP) c, John J. Brooks, MD c
, David G. Brooks, MD b, Helen M. Haupt, MD c, Kirsten Bellucci, MD d, Anne-Marie Martin, PhD e, Victoria Podolski, MT (ASCP) c, John J. Brooks, MD c a Kaiser Permanente Baldwin Park Medical Center, Baldwin Park, California
b Merck Research Laboratories, West Point, Pennsylvania
c Department of Pathology and Laboratory Medicine, Pennsylvania Hospital of the University of Pennsylvania Health System, Philadelphia, Pennsylvania
d Health Network Laboratories, Allentown, Pennsylvania
e Translational Medicine and Genetics, GlaxoSmithKline, Collegeville, Pennsylvania
Correspondence to: Sajjad P. Syed, MD, Department of Pathology and Laboratory Medicine, Kaiser Permanente Baldwin Park Medical Center, 1011 Baldwin Park Blvd, Baldwin Park, CA 91706.| Funding sources: None. |
|
| Conflicts of interest: None declared. |
© 2007
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 57 - N° 5
P. 899-900 - novembre 2007 Retour au numéro
Article précédent
- Adenoma of anogenital mammary-like glands
- Sartaj Ahmed, Ross M. Campbell, Jin Hong Li, Li Juan Wang, Leslie Robinson-Bostom
- Comment on guidelines of care for acne vulgaris management
- Valori Treloar
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?